Fibrinogen in children undergoing cardiac surgery: Is it effective?

Anesthesia and Analgesia

Volumn 99, Issue 5, 2004, Pages 1341-1346

  Miller, Bruce E ^a,b   Tosone, Steven R ^a   Guzzetta, Nina A ^a   Miller, Jennifer L ^a   Brosius, Keith K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST;

ARTICLE; CHILD; HEART SURGERY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ANTIBODIES, MONOCLONAL; BLOOD COAGULATION; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; ELASTICITY; FEMALE; FIBRINOGEN; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFANT; INFANT, NEWBORN; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBELASTOGRAPHY;

EID: 6444233485     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000134811.27812.F0     Document Type: Article

References (25)

1. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
2. Bleyer WA, Hakami N, Shepard TH. The development of hemostasis in the human fetus and newborn infant. J Pediatr 1971;79:838-53.
3. Gordon EM, Ratnoff OD, Saito H, et al. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn. Am J Pediatr Hematol Oncol 1980;2:213-6.
4. Andrew M, Bhogal M, Karpatkin M. Factors XI and XII and prekallikrein in sick and healthy premature infants. N Engl J Med 1981;305:1130-3.
5. von Feiten A, Straub PW. Coagulation studies of cord blood, with special reference to "fetal fibrinogen." Thromb Diath Haemorrh 1969;22:273-80.
6. Teger-Nilsson AC, Ekelund H. Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogen. Thromb Res 1974;5:601-12.
7. Feldman MD, McCrae KR. Clinical coagulation laboratory evaluation of hemostasis in the perioperative period. In: Lake CL, Moore RA, eds. Blood: hemostasis, transfusion, and alternatives in the perioperative period. New York: Raven Press, 1995: 153-78.
8. Galanakis DK, Mosesson MW. Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen. Blood 1976;48:109-18.
9. Witt I, Muller H, Kunzer W. Evidence for the existence of foetal fibrinogen. Thromb Diath Haemorrh 1969;22:101-9.
10. Hamulyak K, Nieuwenhuizen W, Devilee PP, Hemker HC. Reevaluation of some properties of fibrinogen, purified from cord blood of normal newborns. Thromb Res 1983;32:301-10.
11. Tesch R, Trolp R, Witt I. Electron microscopic studies on the foetal fibrin clot. Thromb Res 1979;16:239-43.
12. Kam PCA, Egan MK. Platelet glycoprotein IIb/IIIa antagonists: pharmacology and clinical developments. Anesthesiology 2002; 96:1237-49.
13. de Gaetano G, Bottecchia D, Vermylen J. Effect of platelets on clot structuration: a thrombelastographic study. Thromb Res 1973;3:425-35.
14. Zuckerman L, Cohen E, Vagher JP, et al. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981;46:752-6.
15. Chandler WL. The thromboelastograph and the thromboelastograph technique. Semin Thromb Hemost 1995;21:1-6.
16. Kettner SC, Panzer OP, Kozek SA, et al. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999;89:580-4.
17. Mahla E, Lang T, Vicenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001;92:572-7.
18. Khurana S, Mattson JC, Westley S, et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130: 401-11.
19. Gottumukkala VNR, Sharma SK, Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg 1999;89:1453-5.
20. Greilich PE, Alving BM, O'Neill KL, et al. A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients. Anesth Analg 1997;84:31-8.
21. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Effects of progressive blood loss on coagulation as measured by thrombelastography. Anesth Analg 1987;66:856-63.
22. Miller BE, Guzzetta NA, Tosone SR, et al. Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisons. Anesth Analg 2003;97: 1289-93.
23. McNicol PL, Liu G, Harley ID, et al. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thrombelastography. Anaesth Intensive Care 1994;22: 659-65.
24. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992;54:541-6.
25. Miller BE, Mochizuki T, Levy JH, et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997;85:1196-202.